Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||
| Net Income | -68,863 | -45,934 |
| Depreciation Amortization | 2,455 | 1,547 |
| Accounts payable and accrued liabilities | 476 | 2,041 |
| Other Working Capital | 266 | 7,377 |
| Other Operating Activity | 3,784 | 1,174 |
| Operating Cash Flow | $-61,882 | $-33,795 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 44,059 | -42,217 |
| PPE Investments | -4,883 | -1,594 |
| Investing Cash Flow | $39,176 | $-43,811 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -1,100 | -153 |
| Common Stock Issued | 134 | 83,303 |
| Other Financing Activity | 4,745 | 1,130 |
| Financing Cash Flow | $3,779 | $84,280 |
| Beginning Cash Position | 42,736 | 36,062 |
| End Cash Position | 23,809 | 42,736 |
| Net Cash Flow | $-18,927 | $6,674 |
| Free Cash Flow | ||
| Operating Cash Flow | -61,882 | -33,795 |
| Capital Expenditure | -4,883 | -1,594 |
| Free Cash Flow | -66,765 | -35,389 |